A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions.

Grandhi, B Karthik

A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions. [electronic resource] - Cancer prevention research (Philadelphia, Pa.) Oct 2013 - 1015-1025 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural

1940-6215

10.1158/1940-6207.CAPR-13-0172 doi


Adenocarcinoma--drug therapy
Administration, Oral
Animals
Antineoplastic Agents--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Apoptosis
Aspirin--administration & dosage
Carcinogens--chemistry
Cell Line, Tumor
Cricetinae
Curcumin--administration & dosage
Disease Models, Animal
Disease Progression
Drug Delivery Systems
Immunohistochemistry
In Situ Nick-End Labeling
Isothiocyanates--administration & dosage
Lipids--chemistry
Male
Mesocricetus
Nanoparticles--chemistry
Nitrosamines--chemistry
Pancreatic Neoplasms--drug therapy
Proliferating Cell Nuclear Antigen--chemistry
Sulfoxides